Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


LABbase LIMS

Product Description

LABbase® is a Laboratory Information Management System based on blomesystem®, which comprises all functionalities required for the workflow in a professional laboratory.

The basic configuration of LABbase® includes:
• basic data - general functions and data handling (e.g. user and address administration)
• core LIMS - all information about sample processing of master data up to order and sample data
• audit trail - configurable change history
• storage of binary objects - allocation of files to every record
• limit administration - interactive evaluation of results
• test methods - administration of test methods with test parameters and methods
• units - administration of measurement units and their conversions
• instrument management - administration and testing of instruments and accessories
• sample evaluations and release
• result generation
• report administration / creation of test reports based on templates

Validation and QA
AJ Blomesystem GmbH is DIN EN ISO 9001: 2008 certified. All objects integrated in LABbase have been evaluated using risk analysis and were tested to exhaustion. Any laboratories deciding on LABbase can therefore expect a greatly reduced effort required to validate the LIMS.

Multi Language Support
The user interface and master data can be easily translated into other languages. The applications are currently available in English, French and German.

Multi Location Support
LABbase can support companies with several business locations. With LABbase only one central database is needed - the same master files can be used by all users. Access rights to the data can be defined for individual user groups.

Service

AJ Blomesystem's network of certified service and sales partners guarantees that any customer can be quickly reached by their LIMS specialists. AJ Blomesystem additionally offers comprehensive training programs.

Product LABbase LIMS
Company AJ Blomesystem GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

AJ Blomesystem GmbH
Konrad-Zuse-Str. 1 07745 Jena GERMANY

Tel: +49 3641 779877
Fax: +49 3641 77769800
Email: sales@aj-blomesystem.com



Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!